Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study on Median Effective Concentration of Ciprofol Combined With Remifentanil Via Target-controlled Infusion for Inhibiting Tracheal Intubation Stimulation Under qNOX Index Monitoring
Sponsor: Guangzhou General Hospital of Guangzhou Military Command
Summary
1. The combined induction of intubation with propofol and remifentanil is widely used in clinical anesthesia, primarily through a single intravenous injection. Target-controlled infusion (TCI) technology, which combines pharmacology with clinical practice, offers a more stable and precise infusion mode; 2. This project aims to explore the half-effective concentration (EC50) of propofol combined with remifentanil for inhibiting tracheal intubation stimulation through a sequential approach under the monitoring of qNOX pain index.
Key Details
Gender
All
Age Range
19 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2025-12-01
Completion Date
2026-12-31
Last Updated
2026-03-10
Healthy Volunteers
No
Conditions
Interventions
Cipofol combined with remifentanil administered via target-controlled infusion
Cipofol combined with remifentanil administered via target-controlled infusion for inhibiting tracheal intubation stimulation in adults under qNOX pain index monitoring.
Locations (1)
The Third Affliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China